The Phychem Technologies IPO is a book-built issue valued at ₹14.58 crore. This issue consists entirely of a fresh issue of 27.00 lakh shares.
Subscription for the Phychem Technologies IPO opened on August 31, 2026, and will close on September 2, 2026. Allotment for the IPO is expected to be finalized on September 3, 2026. The IPO will be listed on the BSE SME platform, with the tentative listing date set for September 7, 2026.
The price band for the Phychem Technologies IPO has been fixed at ₹51 to ₹54 per share. The lot size for applications is 2,000 shares. The minimum investment amount for an individual (retail) investor is ₹2,16,000 (4,000 shares), based on the upper price band. For HNI investors, the minimum investment requirement is 3 lots (6,000 shares), amounting to ₹3,24,000.
Hem Securities Ltd. is the book-running lead manager, and MUFG Intime India Pvt. Ltd. is the registrar for the issue. Hem Finlease Pvt. Ltd. is the market maker for the company.
Phychem Technologies Subscription Status
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 510000 | 1800000 | 3.53 |
| HNIs | 390000 | 192000 | 0.49 |
| bHNI | 260000 | 160000 | 0.62 |
| sHNI | 130000 | 32000 | 0.25 |
| Individual | 900000 | 120000 | 0.13 |
| Total | 1800000 | 2112000 | 1.17 |
| Application-Wise Breakup | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 43 | 8 | 0.19 |
| HNIs (3-10L) | 22 | 5 | 0.23 |
| Individual | 225 | 30 | 0.13 |
QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹0.3 | @8% ₹0.3 | @9% ₹0.3 | @10% ₹0.4 | @11% ₹0.4 | @12% ₹0.4 |
Lot Size & Investment
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| INDIVIDUAL | 2 | 4000 | 216000 | 225 |
| sHNI | 3 | 6000 | 324000 | 22 |
| bHNI | 10 | 20000 | 1080000 | 43 |
Share Reservation
| Category | Shares Offered | % |
|---|---|---|
| Total | 2700000 | 100% |
| Anchor | 762000 | 28.22% |
| QIB | 510000 | 18.89% |
| HNI | 390000 | 14.44% |
| INDIVIDUAL | 900000 | 33.33% |
| Market Maker | 138000 | 5.11% |
About the Company
IPO Details
| Total Issue Size | 27,00,000 shares (aggregating up to ₹14.58 Cr) |
| Fresh Issue | 27,00,000 shares (aggregating up to ₹14.58 Cr) |
| Face Value | ₹10/- Per Share |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 75,40,000 shares |
| Share Holding Post Issue | 1,02,40,000 shares |
| Reserved for Market Maker | 1,38,000 shares (aggregating up to ₹0.74 Cr) |
| Market Maker | Hem Finlease Private Limited |
Key Performance Indicators (KPI)
| KPI | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|
| RONW | 29.66% | 29.30% | 24.70% |
| ROCE | 32.73% | 31.99% | 23.27% |
| EPS (BASIC) | 5.42 | 3.77 | 2.25 |
| P/E Pre IPO | 9.96 | ||
| P/E Post IPO | 13.53 |
Company Financial (In ₹Crore)
| Period Ended | Mar-26 | Mar-25 | Mar-24 |
|---|---|---|---|
| Assets | 25.32 | 20.75 | 17.83 |
| Total Income | 57.48 | 51.11 | 47.59 |
| Profit After Tax | 4.08 | 2.84 | 1.69 |
| EBITDA | 6.08 | 4.37 | 2.76 |
| NET Worth | 13.78 | 9.7 | 6.86 |
| Reserves and Surplus | 6.25 | 9.41 | 6.57 |
| Total Borrowing | 5.91 | 4.59 | 5.61 |
COMPARISON WITH INDUSTRY PEERS
*Company does not have any peer group company for comparison with Industry Peer.
About company
Phychem Technologies Limited was incorporated in 2013 as Phychem Technologies Private Limited in Maharashtra. In August 2025, the Company was converted into a public limited company and renamed Phychem Technologies Limited.
Specialized Product Portfolio
The Company manufactures, supplies and exports a wide range of products, including Roto Compounds, Antimicrobial Powders, Foam Compounds, Rotolining Compounds, Stone Effect Powders, Roto Moulding Color Powders, PP Compounds/Powders, Flexible Compounds and Special Purpose Custom Formulations.
End-to-End Rotomoulding Solutions
Phychem also provides Rotolining, Chemical Tanks & Storage Solutions, Custom Molding, Plastic Fabrication, Toll Compounding and Pulverizing. Its specialty includes foam compounds, stone effect powders and rotolining compounds.
Customized & Technology-Driven Solutions
The Company offers customized formulations based on customer requirements and supports customers from material selection through successful moulding and final product processing. Its facility includes a state-of-the-art laboratory-size rotomolding machine with internal temperature measurement and advanced controls, enabling material trials and ready-to-use moulding recipes.
Experienced Leadership
Managing Director Mr. Umakant Savadekar (B.E. Mechanical, M.Tech Nano Science) has 17 years of experience in the rotational moulding industry and understands its technical and commercial requirements. He is also a board member of STAR (Association of Asian Rotomolders).
Vision & Mission
The Company aims to become a global leader and trusted partner in future-ready, high-quality, user- and environment-friendly rotational moulding powder compounds, with a mission to build a specialty manufacturing business through innovation, technical expertise, operational excellence, advanced infrastructure and strategic global alliances.
Strengths
Diversified product portfolio for the roto molding industry: The company offers a wide range of rotational molding compounds catering to various industrial applications. Its customized product offerings enable it to serve customers across construction, agriculture, automotive, water management, and consumer goods sectors.
Long-standing and diversified customer relationships: The company has developed long-term relationships with customers across domestic and international markets. Its diversified customer base and export presence support recurring business opportunities and reduce dependence on a single geography.
Integrated manufacturing and quality infrastructure: The company operates an in-house manufacturing facility equipped with modern machinery, laboratory facilities, and quality control systems. This enables consistent product quality, customized manufacturing, and efficient production processes.
Risk Factors
Dependence on a single manufacturing facility: The company's business is dependent on its manufacturing facility in Nashik. Any disruption due to operational issues, equipment failure, labour disputes, or shutdowns could adversely affect production and financial performance.
Customer concentration risk: A significant portion of the company's revenue is generated from a limited number of major customers without long-term supply agreements. Loss of key customers or reduction in their purchase volumes could adversely impact business operations and profitability.
Dependence on limited raw material suppliers: The company relies heavily on a few suppliers for key raw materials, with its largest supplier accounting for more than half of total purchases over the last three financial years. Any disruption in supply, increase in raw material prices, or quality issues could adversely affect operations and financial results.